Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia
(Press-News.org) COLUMBUS, Ohio - The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
Hairy cell leukemia is a rare form of B-cell blood cancer that is diagnosed in 600 to 800 people annually in the United States. Researchers note that while the disease generally has a good prognosis for the majority of people affected, a small group of patients with variants of the disease do not respond well to existing U.S. Food and Drug Administration (FDA) approved therapies or cannot tolerate the side effects of established therapies.
"There is a critical unmet need for therapy options in this subset of patients to achieve long-term cancer control," said Dr. Kerry Rogers, principal investigator of the clinical trial and a hematologist/scientist at the OSUCCC - James. "Our study shows that ibrutinib (pronounced eye-broo-ti-nib) is a safe, effective and well-tolerated option for patients with relapsed or variant forms of hairy cell leukemia. It is a very important discovery for patients facing this diagnosis."
For this phase 2 clinical trial, a multi-institutional team led by the OSUCCC - James recruited 44 patients with high-risk hairy cell leukemia to test the effectiveness of the drug ibrutinib, 15 of whom were treated in Columbus, Ohio, at the OSUCCC - James.
All study participants had either classic hairy cell leukemia and had received other treatments previously or the variant form of the disease where it is not likely that the standard therapies--the chemotherapy drugs cladribine (pronounced KLAD-rih-been) and pentostatin (pronounced PEN-toh-STA-tin)--would be effective.
Researchers reported their findings in the June 24 issue of Blood.
Ibrutinib is an oral therapy in a class of drugs known as Bruton's tyrosine kinase (BTK) inhibitors. These drugs block specific chemical reactions in the body that are involved in cellular processes. Use of the drug for this study was considered experimental; however, ibrutinib is FDA approved for the treatment of certain cancers, including mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma and others.
"The underlying cellular biology of these diseases is similar, so we wanted to determine if this FDA-approved drug that is used to treat other forms of blood cancer could also serve as an effective treatment for this small segment of hairy cell leukemia patients who did not respond to traditional therapies," said Rogers, who is an assistant professor in Ohio State's College of Medicine.
"Even though hairy cell leukemia is a disease with a generally good prognosis, there is a small group of patients for whom current therapies are inadequate for cancer control," Rogers added. "This is an effective, well-tolerated new treatment option for patients impacted by the highest-risk forms of hairy cell leukemia. It's a very exciting development that could transform survivorship for this subset of patients from months and years, to years and decades."
This study was sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute and grants from the National Cancer Institute/National Institutes of Health and conducted at the OSUCCC - James; the NCI clinical trials center, Karmanos; Mayo Clinic and MD Anderson Cancer Center. The study began in 2013 and is closed to patient accrual.
To learn more about cancer research and patient care at the OSUCCC - James, visit cancer.osu.edu or call 614-293-5066.
ELSE PRESS RELEASES FROM THIS DATE:
Domesticated rabbits come in all sizes and colors, including tiny Netherland Dwarfs, floppy-eared French lops, Flemish Giants, and fluffy Angoras.
These breeds belong to Europe's only rabbit species, originally limited to the Iberian Peninsula and Southern France and used for meat and fur since the last Ice Age, culminating in domestication about 1,500 years ago.
The Americas, on the other hand, have many rabbit species with ranges throughout both continents. The archaeological record shows rabbits were used as extensively in the Americas as they were on the Iberian Peninsula, with clear archaeological evidence that rabbits were being deliberately raised. Why, then, were rabbits domesticated in Europe and not the Americas?
Recent work ...
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a mouse model, leading to much lower viral loads.
Researchers at UChicago's Pritzker School of Molecular Engineering (PME), working with collaborators at Argonne National Laboratory and around the world, also found that the drug could be effective against many types of coronaviruses and picornaviruses. Because of the way it inhibits replication, it ...
Older people appear to have fewer antibodies against the novel coronavirus, a new laboratory study from Oregon Health & Science University suggests.
Antibodies are blood proteins that are made by the immune system to protect against infection. They are known to be key players in protection against SARS-CoV-2 infection.
The study published today in the Journal of the American Medical Association.
"Our older populations are potentially more susceptible to the variants even if they are vaccinated," said senior author Fikadu Tafesse, Ph.D., assistant professor of molecular microbiology and immunology in the OHSU School of Medicine.
Tafesse and colleagues emphasized that even though they measured diminished antibody ...
The average American spends 5 days each year in line by some estimates. Many of these lines are for things like a cup of coffee, movie theater tickets or a ride on the newest roller coaster, but for some the wait is for something far more pressing -- a new kidney.
In South Carolina, the average time spent on a waitlist for a kidney transplant is 42 months, but according to a recent paper in JAMA Surgery, changes to the U.S. kidney allocation system could result in reduced access to kidney transplants and longer times spent in line.
"At face value, the changes in the allocation system seem quite appropriate," said Derek DuBay, M.D., director of ...
Common yeast are able to adapt and thrive in response to a long-term rise in temperature by changing the shape, location and function of some of their proteins. The surprising findings demonstrate the unappreciated plasticity in the molecular and conformational level of proteins and bring the power of molecular biology to the organismal response to climate change. Results from the Zhou lab at the Buck Institute in collaboration with the Si lab from the Stowers Institute are published in Molecular Cell.
Temperature is an unstable parameter in the wild, affecting almost ...
Little is known about the weather at night on Venus as the absence of sunlight makes imaging difficult. Now, researchers have devised a way to use infrared sensors on board the Venus orbiter Akatsuki to reveal the first details of the nighttime weather of our nearest neighbor. Their analytical methods could be used to study other planets including Mars and gas giants as well. Furthermore, the study of Venusian weather granted by their methods could allow researchers to learn more about the mechanisms underpinning Earth's weather systems.
Earth and Venus ...
Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) have succeeded in creating the first genetically engineered marsupial. This study, published in the scientific journal Current Biology, will contribute to deciphering the genetic background of unique characteristics observed only in marsupials.
Genetically modified animals, particularly mice and rats, are extremely important tools for researching biological processes. For example, researchers often silence genes to find out what their normal functions are. Since marsupials have unique characteristics, studying them requires developing ...
During cell division, chromosomes are duplicated and separated so that one copy of each chromosome is inherited by each of the two emerging daughter cells. Correct distribution of chromosomes requires high accuracy and defects in this process can cause aberrant distribution of chromosomes and facilitate cancer development. By analyzing the structure of the protein responsible for chromosome separation, an international team, led by scientists from the University of Geneva (UNIGE), has shed light on the mechanisms controlling this essential player in cell division. This work is published in the journal ...
MIT physicists have observed signs of a rare type of superconductivity in a material called magic-angle twisted trilayer graphene. In a study appearing in Nature, the researchers report that the material exhibits superconductivity at surprisingly high magnetic fields of up to 10 Tesla, which is three times higher than what the material is predicted to endure if it were a conventional superconductor.
The results strongly imply that magic-angle trilayer graphene, which was initially discovered by the same group, is a very rare type of superconductor, known as a "spin-triplet," that is impervious to high ...
What The Study Did: This study at an institution of higher education in Colorado evaluated the association between self-reported protective behaviors and how common SARS-CoV-2 infection was among essential in-person employees during the first six months of the COVID-19 pandemic in the United States.
Authors: Tracy L. Nelson, M.P.H., Ph.D., of Colorado State University in Fort Collins, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor's Note: The article includes conflict of interest and funding/support disclosures. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia